RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

This study has been completed.
Sponsor:
Information provided by:
Institute of Child Health
ClinicalTrials.gov Identifier:
NCT00564915
First received: November 28, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
  Purpose

A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.


Condition Intervention Phase
Epilepsy
Dietary Supplement: Ketogenic diet
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

Resource links provided by NLM:


Further study details as provided by Institute of Child Health:

Primary Outcome Measures:
  • Change in seizure frequency [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Tolerability and assessment of ketosis and growth [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 145
Study Start Date: December 2001
Study Completion Date: July 2006
Intervention Details:
    Dietary Supplement: Ketogenic diet
    Ketogenic diet
  Eligibility

Ages Eligible for Study:   2 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of epilepsy for at least 2 years, resistant to at least two AEDs, at least 7 seizures/week
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00564915

Locations
United Kingdom
Institute of Child Health, The Wolfson Centre
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Investigators
Principal Investigator: Helen Cross, Professor UCL Institute of Child Health
  More Information

No publications provided

Responsible Party: Tracy Assari, Institute of Child Health
ClinicalTrials.gov Identifier: NCT00564915     History of Changes
Other Study ID Numbers: 98NR04
Study First Received: November 28, 2007
Last Updated: November 28, 2007
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Institute of Child Health:
Epilepsy

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on October 19, 2014